FDA grants an additional orphan drug designation to Senhwa Biosciences silmitasertib, this time to treat patients with medulloblastoma.
FDA warns Maumee, OH,-based Spartan Chemical Company about CGMP violations in its production of misbranded unapproved new drugs.
Taro recalls one lot of clobetasol propionate ointment due to microbial contamination
FDA grants an additional orphan drug designation to Senhwa Biosciences silmitasertib, this time to treat patients with medulloblastoma.
FDA authorizes marketing of the Philips CavaClear Laser Sheath to assist in removing some inferior vena cava filters.
FDA approves Viivs Apretude injection for HIV pre-exposure prophylaxis.
Viona Pharmaceuticals recalls 33 lots of metformin HCl extended-release 750 mg tablets due to possible NDMA contamination.
FDA approves a new pediatric indication and new dosage form for Janssens Xarelto.